HomepageMedicineFDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors Medicine FDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors admin Posted on March 28, 2024 Action marks the first FDA-approved blood screening test for malaria. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostSquamous Cell Carcinoma in Cats: Causes, Signs & Treatments (Vet Answer) Next PostHas the Luxury E-Commerce Bubble Burst? You Might Also Like Medicine Pharma Pulse 7/5/24: The Impact of FDA's Diversity Action Plan, Apple Poised to Get OpenAI Board Observer Role & more admin July 6, 2024 Medicine AstraZeneca Acquires Amolyt Pharma with the Aim of Developing Rare Endocrine Disease Treatments admin March 15, 2024 Medicine Gilead Discontinuing Development of Magrolimab in Hematologic Cancers Following Full Clinical Hold by FDA for Increased Risk of Death admin February 8, 2024 Medicine FDA Grants Priority Review to Dupixent for Uncontrolled Chronic Obstructive Pulmonary Disease admin February 25, 2024
Medicine Pharma Pulse 7/5/24: The Impact of FDA's Diversity Action Plan, Apple Poised to Get OpenAI Board Observer Role & more admin July 6, 2024
Medicine AstraZeneca Acquires Amolyt Pharma with the Aim of Developing Rare Endocrine Disease Treatments admin March 15, 2024
Medicine Gilead Discontinuing Development of Magrolimab in Hematologic Cancers Following Full Clinical Hold by FDA for Increased Risk of Death admin February 8, 2024
Medicine FDA Grants Priority Review to Dupixent for Uncontrolled Chronic Obstructive Pulmonary Disease admin February 25, 2024